Cause analysis and prevention of drug shortage in medical institutions

LI Peifang; FANG Yan; ZHANG Shantang; ZHOU Baozhu

doi:10.3969/j.issn.1006-0111.2015.02.024

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To analyze the reason of drug shortages in medical institutions and take corresponding prevention measures to ensure drug supply. Methods The drug outbound orders in 2012 were retrospectively analyzed to trace the procurement plan of badly-needed drugs and the delivery time of supplier. Excel was used to carry out classification and statistics for the information of drug shortages combined with the explanations that the supplier failed to supply to summarize the external cause and internal cause of drug shortages in medical institutions. Results In 2012, the dispensing department received a total of 46862 plans, and 1423 items were badly-needed drugs.The drug shortage rate was 3.0%. 643 times of drug shortages were caused by external causes which accountedfor 45.2% of all the shortages; 780 times of the drug shortages were caused by internal causes which accounted for 54.8%. Price inversion accounted for 40.7% in the external causes that lead to the drug shortages, and it was the top of the external causes for drug shortages. The low-priced small varieties and generic drugs accounted for 71.2% of drug shortages caused by external causes; in the internal causes of drug shortages, the inventory control accounted for 45.0%, ranked the first. Conclusion The scientific and reasonable drug price, the improvement of bidding policy, the joint effort of all parties of drug supply chain, and the enhancement of the early warning and management of the badly-needed drugs can reduce drug shortage.

Cause analysis and prevention of drug shortage in medical institutions

Department of Pharmacy, Anhui Provincial Hospital, Hefei 230001, China

Received Date: 2013-11-29

Rev Recd Date: 2014-07-10

Key words:

Abstract: Objective To analyze the reason of drug shortages in medical institutions and take corresponding prevention measures to ensure drug supply. Methods The drug outbound orders in 2012 were retrospectively analyzed to trace the procurement plan of badly-needed drugs and the delivery time of supplier. Excel was used to carry out classification and statistics for the information of drug shortages combined with the explanations that the supplier failed to supply to summarize the external cause and internal cause of drug shortages in medical institutions. Results In 2012, the dispensing department received a total of 46862 plans, and 1423 items were badly-needed drugs.The drug shortage rate was 3.0%. 643 times of drug shortages were caused by external causes which accountedfor 45.2% of all the shortages; 780 times of the drug shortages were caused by internal causes which accounted for 54.8%. Price inversion accounted for 40.7% in the external causes that lead to the drug shortages, and it was the top of the external causes for drug shortages. The low-priced small varieties and generic drugs accounted for 71.2% of drug shortages caused by external causes; in the internal causes of drug shortages, the inventory control accounted for 45.0%, ranked the first. Conclusion The scientific and reasonable drug price, the improvement of bidding policy, the joint effort of all parties of drug supply chain, and the enhancement of the early warning and management of the badly-needed drugs can reduce drug shortage.

HTML

Reference (8)

[1]	赵志刚, 朱乐婷, 王莉文.全国11 省市42 家医院临床应用药品供应短缺现状调研分析[J].中国医院药学杂志, 2008,28 (1):65-66.
[2]	戴岱,江滨,韩晟,等.我国短缺药品现状调查分析[J].中国药房,2010,21(9):785-787.
[3]	冯洁.药品供应工作中缺货情况分析及应对措施[J].中国医院药学杂志,2012,32(1):52-54.
[4]	姜思通,王志,刘晓燕.2007年我院药品供应短缺品种分析[J].中国药业,2008,17(20):53.
[5]	郭莹,张惠玲,陈晶,等. 日本药品价格政策研究及对我国的启示[J].中国药物经济学,2010(4):63-67.
[6]	姚立新,Boehm G,郑强.美国药品短缺及FDA采取的应对策略[J].中国新药杂志,2012,21(20):2359-2367.
[7]	张翠莲,梅丹, 李大魁.我国应对部分药品短缺的策略初探[J].中国药房,2009:20(25):1933-1935.
[8]	张海波,姜宁玲,王长青.部分药品短缺的成因分析与应对策略[J].南京医科大学学报,2012,4(2):115-117.

[1]	赵志刚, 朱乐婷, 王莉文.全国11 省市42 家医院临床应用药品供应短缺现状调研分析[J].中国医院药学杂志, 2008,28 (1):65-66.
[2]	戴岱,江滨,韩晟,等.我国短缺药品现状调查分析[J].中国药房,2010,21(9):785-787.
[3]	冯洁.药品供应工作中缺货情况分析及应对措施[J].中国医院药学杂志,2012,32(1):52-54.
[4]	姜思通,王志,刘晓燕.2007年我院药品供应短缺品种分析[J].中国药业,2008,17(20):53.
[5]	郭莹,张惠玲,陈晶,等. 日本药品价格政策研究及对我国的启示[J].中国药物经济学,2010(4):63-67.
[6]	姚立新,Boehm G,郑强.美国药品短缺及FDA采取的应对策略[J].中国新药杂志,2012,21(20):2359-2367.
[7]	张翠莲,梅丹, 李大魁.我国应对部分药品短缺的策略初探[J].中国药房,2009:20(25):1933-1935.
[8]	张海波,姜宁玲,王长青.部分药品短缺的成因分析与应对策略[J].南京医科大学学报,2012,4(2):115-117.

Message Board

Cause analysis and prevention of drug shortage in medical institutions

doi: 10.3969/j.issn.1006-0111.2015.02.024

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views